Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Adoptive Cell Transfer Therapy
1.2 Key Market Segments
1.2.1 Adoptive Cell Transfer Therapy Segment by Type
1.2.2 Adoptive Cell Transfer Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Adoptive Cell Transfer Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Adoptive Cell Transfer Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Adoptive Cell Transfer Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Adoptive Cell Transfer Therapy Market Competitive Landscape
3.1 Global Adoptive Cell Transfer Therapy Sales by Manufacturers (2019-2024)
3.2 Global Adoptive Cell Transfer Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Adoptive Cell Transfer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Adoptive Cell Transfer Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Adoptive Cell Transfer Therapy Sales Sites, Area Served, Product Type
3.6 Adoptive Cell Transfer Therapy Market Competitive Situation and Trends
3.6.1 Adoptive Cell Transfer Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Adoptive Cell Transfer Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Adoptive Cell Transfer Therapy Industry Chain Analysis
4.1 Adoptive Cell Transfer Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Adoptive Cell Transfer Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Adoptive Cell Transfer Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Adoptive Cell Transfer Therapy Sales Market Share by Type (2019-2024)
6.3 Global Adoptive Cell Transfer Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Adoptive Cell Transfer Therapy Price by Type (2019-2024)
7 Adoptive Cell Transfer Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Adoptive Cell Transfer Therapy Market Sales by Application (2019-2024)
7.3 Global Adoptive Cell Transfer Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Adoptive Cell Transfer Therapy Sales Growth Rate by Application (2019-2024)
8 Adoptive Cell Transfer Therapy Market Segmentation by Region
8.1 Global Adoptive Cell Transfer Therapy Sales by Region
8.1.1 Global Adoptive Cell Transfer Therapy Sales by Region
8.1.2 Global Adoptive Cell Transfer Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Adoptive Cell Transfer Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Adoptive Cell Transfer Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Adoptive Cell Transfer Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Adoptive Cell Transfer Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Adoptive Cell Transfer Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Novartis AG
9.1.1 Novartis AG Adoptive Cell Transfer Therapy Basic Information
9.1.2 Novartis AG Adoptive Cell Transfer Therapy Product Overview
9.1.3 Novartis AG Adoptive Cell Transfer Therapy Product Market Performance
9.1.4 Novartis AG Business Overview
9.1.5 Novartis AG Adoptive Cell Transfer Therapy SWOT Analysis
9.1.6 Novartis AG Recent Developments
9.2 Kite Pharma
9.2.1 Kite Pharma Adoptive Cell Transfer Therapy Basic Information
9.2.2 Kite Pharma Adoptive Cell Transfer Therapy Product Overview
9.2.3 Kite Pharma Adoptive Cell Transfer Therapy Product Market Performance
9.2.4 Kite Pharma Business Overview
9.2.5 Kite Pharma Adoptive Cell Transfer Therapy SWOT Analysis
9.2.6 Kite Pharma Recent Developments
9.3 Pfizer
9.3.1 Pfizer Adoptive Cell Transfer Therapy Basic Information
9.3.2 Pfizer Adoptive Cell Transfer Therapy Product Overview
9.3.3 Pfizer Adoptive Cell Transfer Therapy Product Market Performance
9.3.4 Pfizer Adoptive Cell Transfer Therapy SWOT Analysis
9.3.5 Pfizer Business Overview
9.3.6 Pfizer Recent Developments
9.4 Juno Therapeutics
9.4.1 Juno Therapeutics Adoptive Cell Transfer Therapy Basic Information
9.4.2 Juno Therapeutics Adoptive Cell Transfer Therapy Product Overview
9.4.3 Juno Therapeutics Adoptive Cell Transfer Therapy Product Market Performance
9.4.4 Juno Therapeutics Business Overview
9.4.5 Juno Therapeutics Recent Developments
9.5 Celgene Corporation
9.5.1 Celgene Corporation Adoptive Cell Transfer Therapy Basic Information
9.5.2 Celgene Corporation Adoptive Cell Transfer Therapy Product Overview
9.5.3 Celgene Corporation Adoptive Cell Transfer Therapy Product Market Performance
9.5.4 Celgene Corporation Business Overview
9.5.5 Celgene Corporation Recent Developments
9.6 CARsgen Therapeutics
9.6.1 CARsgen Therapeutics Adoptive Cell Transfer Therapy Basic Information
9.6.2 CARsgen Therapeutics Adoptive Cell Transfer Therapy Product Overview
9.6.3 CARsgen Therapeutics Adoptive Cell Transfer Therapy Product Market Performance
9.6.4 CARsgen Therapeutics Business Overview
9.6.5 CARsgen Therapeutics Recent Developments
9.7 Sorrento Therapeutics
9.7.1 Sorrento Therapeutics Adoptive Cell Transfer Therapy Basic Information
9.7.2 Sorrento Therapeutics Adoptive Cell Transfer Therapy Product Overview
9.7.3 Sorrento Therapeutics Adoptive Cell Transfer Therapy Product Market Performance
9.7.4 Sorrento Therapeutics Business Overview
9.7.5 Sorrento Therapeutics Recent Developments
9.8 Legend Biotech
9.8.1 Legend Biotech Adoptive Cell Transfer Therapy Basic Information
9.8.2 Legend Biotech Adoptive Cell Transfer Therapy Product Overview
9.8.3 Legend Biotech Adoptive Cell Transfer Therapy Product Market Performance
9.8.4 Legend Biotech Business Overview
9.8.5 Legend Biotech Recent Developments
9.9 Atara Biotherapeutics
9.9.1 Atara Biotherapeutics Adoptive Cell Transfer Therapy Basic Information
9.9.2 Atara Biotherapeutics Adoptive Cell Transfer Therapy Product Overview
9.9.3 Atara Biotherapeutics Adoptive Cell Transfer Therapy Product Market Performance
9.9.4 Atara Biotherapeutics Business Overview
9.9.5 Atara Biotherapeutics Recent Developments
9.10 Aurora Biopharma
9.10.1 Aurora Biopharma Adoptive Cell Transfer Therapy Basic Information
9.10.2 Aurora Biopharma Adoptive Cell Transfer Therapy Product Overview
9.10.3 Aurora Biopharma Adoptive Cell Transfer Therapy Product Market Performance
9.10.4 Aurora Biopharma Business Overview
9.10.5 Aurora Biopharma Recent Developments
9.11 Autolus Therapeutics PLC
9.11.1 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Basic Information
9.11.2 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Product Overview
9.11.3 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Product Market Performance
9.11.4 Autolus Therapeutics PLC Business Overview
9.11.5 Autolus Therapeutics PLC Recent Developments
9.12 Bluebird
9.12.1 Bluebird Adoptive Cell Transfer Therapy Basic Information
9.12.2 Bluebird Adoptive Cell Transfer Therapy Product Overview
9.12.3 Bluebird Adoptive Cell Transfer Therapy Product Market Performance
9.12.4 Bluebird Business Overview
9.12.5 Bluebird Recent Developments
9.13 Carina Biotech
9.13.1 Carina Biotech Adoptive Cell Transfer Therapy Basic Information
9.13.2 Carina Biotech Adoptive Cell Transfer Therapy Product Overview
9.13.3 Carina Biotech Adoptive Cell Transfer Therapy Product Market Performance
9.13.4 Carina Biotech Business Overview
9.13.5 Carina Biotech Recent Developments
9.14 Athenex
9.14.1 Athenex Adoptive Cell Transfer Therapy Basic Information
9.14.2 Athenex Adoptive Cell Transfer Therapy Product Overview
9.14.3 Athenex Adoptive Cell Transfer Therapy Product Market Performance
9.14.4 Athenex Business Overview
9.14.5 Athenex Recent Developments
9.15 Xiangxue Pharmaceutical (Xiangxue Precision)
9.15.1 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Basic Information
9.15.2 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Product Overview
9.15.3 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Product Market Performance
9.15.4 Xiangxue Pharmaceutical (Xiangxue Precision) Business Overview
9.15.5 Xiangxue Pharmaceutical (Xiangxue Precision) Recent Developments
9.16 Hengrui Yuanzheng
9.16.1 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Basic Information
9.16.2 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Product Overview
9.16.3 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Product Market Performance
9.16.4 Hengrui Yuanzheng Business Overview
9.16.5 Hengrui Yuanzheng Recent Developments
9.17 Eureka Therapeutics
9.17.1 Eureka Therapeutics Adoptive Cell Transfer Therapy Basic Information
9.17.2 Eureka Therapeutics Adoptive Cell Transfer Therapy Product Overview
9.17.3 Eureka Therapeutics Adoptive Cell Transfer Therapy Product Market Performance
9.17.4 Eureka Therapeutics Business Overview
9.17.5 Eureka Therapeutics Recent Developments
9.18 WuXi Juno
9.18.1 WuXi Juno Adoptive Cell Transfer Therapy Basic Information
9.18.2 WuXi Juno Adoptive Cell Transfer Therapy Product Overview
9.18.3 WuXi Juno Adoptive Cell Transfer Therapy Product Market Performance
9.18.4 WuXi Juno Business Overview
9.18.5 WuXi Juno Recent Developments
9.19 Shenzhen Inno Immunity
9.19.1 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Basic Information
9.19.2 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Product Overview
9.19.3 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Product Market Performance
9.19.4 Shenzhen Inno Immunity Business Overview
9.19.5 Shenzhen Inno Immunity Recent Developments
9.20 Shenzhen Binde Bio
9.20.1 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Basic Information
9.20.2 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Product Overview
9.20.3 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Product Market Performance
9.20.4 Shenzhen Binde Bio Business Overview
9.20.5 Shenzhen Binde Bio Recent Developments
9.21 Kerui Bio
9.21.1 Kerui Bio Adoptive Cell Transfer Therapy Basic Information
9.21.2 Kerui Bio Adoptive Cell Transfer Therapy Product Overview
9.21.3 Kerui Bio Adoptive Cell Transfer Therapy Product Market Performance
9.21.4 Kerui Bio Business Overview
9.21.5 Kerui Bio Recent Developments
9.22 Adaptimmune
9.22.1 Adaptimmune Adoptive Cell Transfer Therapy Basic Information
9.22.2 Adaptimmune Adoptive Cell Transfer Therapy Product Overview
9.22.3 Adaptimmune Adoptive Cell Transfer Therapy Product Market Performance
9.22.4 Adaptimmune Business Overview
9.22.5 Adaptimmune Recent Developments
9.23 Altor Bioscience Corporation
9.23.1 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Basic Information
9.23.2 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Product Overview
9.23.3 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Product Market Performance
9.23.4 Altor Bioscience Corporation Business Overview
9.23.5 Altor Bioscience Corporation Recent Developments
9.24 Cellectis
9.24.1 Cellectis Adoptive Cell Transfer Therapy Basic Information
9.24.2 Cellectis Adoptive Cell Transfer Therapy Product Overview
9.24.3 Cellectis Adoptive Cell Transfer Therapy Product Market Performance
9.24.4 Cellectis Business Overview
9.24.5 Cellectis Recent Developments
9.25 Takara Bio
9.25.1 Takara Bio Adoptive Cell Transfer Therapy Basic Information
9.25.2 Takara Bio Adoptive Cell Transfer Therapy Product Overview
9.25.3 Takara Bio Adoptive Cell Transfer Therapy Product Market Performance
9.25.4 Takara Bio Business Overview
9.25.5 Takara Bio Recent Developments
9.26 Unum Therapeutics
9.26.1 Unum Therapeutics Adoptive Cell Transfer Therapy Basic Information
9.26.2 Unum Therapeutics Adoptive Cell Transfer Therapy Product Overview
9.26.3 Unum Therapeutics Adoptive Cell Transfer Therapy Product Market Performance
9.26.4 Unum Therapeutics Business Overview
9.26.5 Unum Therapeutics Recent Developments
10 Adoptive Cell Transfer Therapy Market Forecast by Region
10.1 Global Adoptive Cell Transfer Therapy Market Size Forecast
10.2 Global Adoptive Cell Transfer Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Adoptive Cell Transfer Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Adoptive Cell Transfer Therapy Market Size Forecast by Region
10.2.4 South America Adoptive Cell Transfer Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Adoptive Cell Transfer Therapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Adoptive Cell Transfer Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Adoptive Cell Transfer Therapy by Type (2025-2030)
11.1.2 Global Adoptive Cell Transfer Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Adoptive Cell Transfer Therapy by Type (2025-2030)
11.2 Global Adoptive Cell Transfer Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Adoptive Cell Transfer Therapy Sales (K Units) Forecast by Application
11.2.2 Global Adoptive Cell Transfer Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
